These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Self-rated health predicts adverse events during β-blocker treatment: the CIBIS-ELD randomised trial analysis. Lainscak M; Farkas J; Inkrot S; Gelbrich G; Neskovic AN; Rau T; Tahirovic E; Töpper A; Apostolovic S; Haverkamp W; Herrmann-Lingen C; Anker SD; Düngen HD Int J Cardiol; 2013 Feb; 163(1):87-92. PubMed ID: 21652093 [TBL] [Abstract][Full Text] [Related]
6. Bisoprolol and heart failure: new frontiers. Chopra HK Indian Heart J; 2010; 62(1):7-12. PubMed ID: 21180027 [TBL] [Abstract][Full Text] [Related]
7. Titration to target dose of bisoprolol vs. carvedilol in elderly patients with heart failure: the CIBIS-ELD trial. Düngen HD; Apostolovic S; Inkrot S; Tahirovic E; Töpper A; Mehrhof F; Prettin C; Putnikovic B; Neskovic AN; Krotin M; Sakac D; Lainscak M; Edelmann F; Wachter R; Rau T; Eschenhagen T; Doehner W; Anker SD; Waagstein F; Herrmann-Lingen C; Gelbrich G; Dietz R; Eur J Heart Fail; 2011 Jun; 13(6):670-80. PubMed ID: 21429992 [TBL] [Abstract][Full Text] [Related]
8. Regional differences in health-related quality of life in elderly heart failure patients: results from the CIBIS-ELD trial. Chavanon ML; Inkrot S; Zelenak C; Tahirovic E; Stanojevic D; Apostolovic S; Sljivic A; Ristic AD; Matic D; Loncar G; Veskovic J; Zdravkovic M; Lainscak M; Pieske B; Herrmann-Lingen C; Düngen HD Clin Res Cardiol; 2017 Aug; 106(8):645-655. PubMed ID: 28361371 [TBL] [Abstract][Full Text] [Related]
9. Regional differences among female patients with heart failure from the Cardiac Insufficiency BIsoprolol Study in ELDerly (CIBIS-ELD). Apostolovic S; Stanojevic D; Lainscak M; Gelbrich G; Jankovic-Tomasevic R; Pavlovic M; Djordjevic-Radojkovic D; Salinger-Martinovic S; Putnikovic B; Radovanovic S; Waagstein F; Tomasevic M; Tahirovic E; Inkrot S; Musial-Bright L; Düngen HD Cardiol J; 2014; 21(3):265-72. PubMed ID: 23990195 [TBL] [Abstract][Full Text] [Related]
10. Bisoprolol vs. carvedilol in elderly patients with heart failure: rationale and design of the CIBIS-ELD trial. Düngen HD; Apostolović S; Inkrot S; Tahirović E; Krackhardt F; Pavlović M; Putniković B; Lainscak M; Gelbrich G; Edelmann F; Wachter R; Eschenhagen T; Waagstein F; Follath F; Rauchhaus M; Haverkamp W; Osterziel KJ; Dietz R; Clin Res Cardiol; 2008 Sep; 97(9):578-86. PubMed ID: 18542839 [TBL] [Abstract][Full Text] [Related]
11. Ivabradine improves quality of life in subjects with chronic heart failure compared to treatment with β-blockers: results of a multicentric observational APULIA study. Riccioni G; Masciocco L; Benvenuto A; Saracino P; De Viti D; Massari F; Meliota G; Buta F; Speziale G Pharmacology; 2013; 92(5-6):276-80. PubMed ID: 24296869 [TBL] [Abstract][Full Text] [Related]
12. Comparison of effectiveness of carvedilol versus bisoprolol for prevention of postdischarge atrial fibrillation after coronary artery bypass grafting in patients with heart failure. Marazzi G; Iellamo F; Volterrani M; Caminiti G; Madonna M; Arisi G; Massaro R; Righi D; Rosano GM Am J Cardiol; 2011 Jan; 107(2):215-9. PubMed ID: 21129714 [TBL] [Abstract][Full Text] [Related]
13. The effects of beta-blockers in patients with stable chronic heart failure. Predictors of left ventricular ejection fraction improvement and impact on prognosis. de Groote P; Delour P; Mouquet F; Lamblin N; Dagorn J; Hennebert O; Le Tourneau T; Foucher-Hossein C; Verkindère C; Bauters C Am Heart J; 2007 Sep; 154(3):589-95. PubMed ID: 17719311 [TBL] [Abstract][Full Text] [Related]
14. Tolerability and Feasibility of Beta-Blocker Titration in HFpEF Versus HFrEF: Insights From the CIBIS-ELD Trial. Edelmann F; Musial-Bright L; Gelbrich G; Trippel T; Radenovic S; Wachter R; Inkrot S; Loncar G; Tahirovic E; Celic V; Veskovic J; Zdravkovic M; Lainscak M; Apostolović S; Neskovic AN; Pieske B; Düngen HD; JACC Heart Fail; 2016 Feb; 4(2):140-149. PubMed ID: 26682793 [TBL] [Abstract][Full Text] [Related]
15. Impact of the β1-adrenoceptor Arg389Gly polymorphism on heart-rate responses to bisoprolol and carvedilol in heart-failure patients. Rau T; Düngen HD; Edelmann F; Waagstein F; Lainščak M; Dimković S; Apostolović S; Nešković AN; Haverkamp W; Gelbrich G; Eschenhagen T Clin Pharmacol Ther; 2012 Jul; 92(1):21-8. PubMed ID: 22617224 [TBL] [Abstract][Full Text] [Related]
16. Differences between bisoprolol and carvedilol in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized trial. Lainscak M; Podbregar M; Kovacic D; Rozman J; von Haehling S Respir Med; 2011 Oct; 105 Suppl 1():S44-9. PubMed ID: 22015086 [TBL] [Abstract][Full Text] [Related]
17. Effect of selective and nonselective beta-blockers on resting energy production rate and total body substrate utilization in chronic heart failure. Podbregar M; Voga G J Card Fail; 2002 Dec; 8(6):369-78. PubMed ID: 12528088 [TBL] [Abstract][Full Text] [Related]
18. Switching from carvedilol to bisoprolol ameliorates adverse effects in heart failure patients with dizziness or hypotension. Taniguchi T; Ohtani T; Mizote I; Kanzaki M; Ichibori Y; Minamiguchi H; Asano Y; Sakata Y; Komuro I J Cardiol; 2013 Jun; 61(6):417-22. PubMed ID: 23548374 [TBL] [Abstract][Full Text] [Related]
19. Influence of order and type of drug (bisoprolol vs. enalapril) on outcome and adverse events in patients with chronic heart failure: a post hoc analysis of the CIBIS-III trial. Funck-Brentano C; van Veldhuisen DJ; van de Ven LL; Follath F; Goulder M; Willenheimer R; Eur J Heart Fail; 2011 Jul; 13(7):765-72. PubMed ID: 21551161 [TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of carvedilol in very elderly diabetic patients with heart failure. Del Sindaco D; Pulignano G; Cioffi G; Tarantini L; Di Lenarda A; De Feo S; Opasich C; Minardi G; Giovannini E; Leggio F J Cardiovasc Med (Hagerstown); 2007 Sep; 8(9):675-82. PubMed ID: 17700396 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]